Schrodinger (NASDAQ:SDGR – Get Free Report) and VSee Health (NASDAQ:VSEE – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.
Profitability
This table compares Schrodinger and VSee Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Schrodinger | -20.98% | -16.37% | -8.19% |
| VSee Health | -92.36% | -11,636.34% | -68.62% |
Institutional & Insider Ownership
79.0% of Schrodinger shares are held by institutional investors. Comparatively, 1.0% of VSee Health shares are held by institutional investors. 10.1% of Schrodinger shares are held by insiders. Comparatively, 14.9% of VSee Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Schrodinger | $255.87 million | 7.47 | -$103.26 million | ($0.74) | -34.99 |
| VSee Health | $14.46 million | 0.49 | -$14.71 million | ($0.37) | -5.27 |
VSee Health has lower revenue, but higher earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than VSee Health, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Schrodinger and VSee Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Schrodinger | 1 | 2 | 4 | 1 | 2.62 |
| VSee Health | 1 | 0 | 0 | 0 | 1.00 |
Schrodinger presently has a consensus price target of $23.50, indicating a potential downside of 9.23%. Given Schrodinger’s stronger consensus rating and higher possible upside, analysts clearly believe Schrodinger is more favorable than VSee Health.
Summary
Schrodinger beats VSee Health on 10 of the 14 factors compared between the two stocks.
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
About VSee Health
VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
